Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation
Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng
Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng
View: Text | PDF
Research Article Angiogenesis Vascular biology

Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation

  • Text
  • PDF
Abstract

Loss-of-function mutations in cerebral cavernous malformation (CCM) genes and gain-of-function mutation in the MAP3K3 gene encoding MEKK3 cause CCM. Deficiency of CCM proteins leads to the activation of MEKK3-KLF2/4 signaling, but it is not clear how this occurs. Here, we demonstrate that deletion of the CCM3 interacting kinases STK24/25 in endothelial cells causes defects in vascular patterning during development as well as CCM lesion formation during postnatal life. While permanent deletion of STK24/25 in endothelial cells caused developmental defects of the vascular system, inducible postnatal deletion of STK24/25 impaired angiogenesis in the retina and brain. More importantly, deletion of STK24/25 in neonatal mice led to the development of severe CCM lesions. At the molecular level, a hybrid protein consisting of the STK kinase domain and the MEKK3 interacting domain of CCM2 rescued the vascular phenotype caused by the loss of ccm gene function in zebrafish. Our study suggests that CCM2/3 proteins act as adapters to allow recruitment of STK24/25 to limit the constitutive MEKK3 activity, thus contributing to vessel stability. Loss of STK24/25 causes MEKK3 activation, leading to CCM lesion formation.

Authors

Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng

×

Figure 1

Deletion of Stk24 and Stk25 in endothelium results in vascular defects during embryonic development.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Stk24 and Stk25 in endothelium results in vascular defects d...
(A) Stereomicroscopic images of developmental time course of littermate Stk24fl/fl;Stk25fl/fl and Stk24/25dECKO mice. Scale bars: 1 mm. (B) H&E staining and Pecam immunostaining of transverse sections of E10 Stk24fl/fl;Stk25fl/fl (n = 3) and Stk24/25dECKO (n = 4) embryos reveal the presence of normally lumenized dorsal aortas (DA) in the Stk24fl/fl;Stk25fl/fl embryos but not in Stk24/25dECKO embryos. White arrowheads indicate dorsal aortas. Scale bars: 100 μm. (C) Images of E9.5 embryo hearts of Stk24fl/fl;Stk25fl/fl (n = 9) and Stk24/25dECKO (n = 6) embryos with injection of Indian ink. Upper and middle panels show embryo overview and magnification of the boxed regions, showing injected ink flows primarily through the second and third BAA to fill the DA in the Stk24fl/fl;Stk25fl/fl embryos. In contrast, ink injected into the heart of Stk24/25dECKO embryos failed to opacify the DA. Accumulation of ink was observed in the heart due to the narrow BAA. Scale bars: 500 μm. Lower panel shows whole-mount immunostaining for the endothelial cell marker, endoglin, showing narrowed BAA and adjacent DA (red arrows) in Stk24/25dECKO embryos. Scale bars: 100μm. (D) Whole-mount immunostaining with endoglin showing the impaired vascular patterning (indicated by the white arrows) in the brain of E9.5 Stk24/25dECKO (n = 6) embryos in comparison with that of Stk24fl/fl;Stk25fl/fl (n = 3) littermate control embryos. Scale bars: 500 μm in overview panels and 100 μm in magnified panels. All the images presented are representatives of 3 or more independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts